2026 International Congress Archives - Page 86 of 208

Pain Assessment using Parkinson’s Disease Pain Classification System (PD-PCS) and King’s Parkinson Disease Pain Scale (KPPS) – a Comparative Study

JW. Queiroz, PC. Matos, A. Ferreira Gomes, C. Listik, E. Listik, F. Rolim, D. de Andrade, F. Carvalho (Fortaleza, Brazil)
Pain in Multiple System Atrophy: a healthcare professionals’ survey

N. Campese, B. Caliò, F. Leys, D. Bendetowicz, G. Calandra Buonaura, K. Ray Chaudhuri, E. Coon, JC. Curtis, G. Deuschl, G. Devigili, R. Eleopra, M. Fabbri, C. Falup-Pecurariu, R. Freeman, F. Gandor, G. Göbel, P. Guaraldi, G. Höglinger, H. Kaufmann, A. Pavy-Le Traon, J. Levin, S. Lorenzl, WG. Meissner, V. Mylius, MT. Pellecchia, W. Poewe, A. Schlager, A. Schrag, K. Seppi, M. Tinazzi, J. Wanschitz, L. Zamarian, A. Fanciulli (Innsbruck, Austria)
Pain Inverts the Relationship Between Beta-band Power and Fatigue Severity in PD: an EEG Study

A. Hurtado-Martínez, M. Martín-Buro García-Dionisio, Y. González-Zamorano, M. Moreno-Verdú, F. Sánchez-Cuesta, JP. Romero-Muñoz (Pozuelo de Alarcón, Spain)
Pain Management in Parkinson’s Disease: The Role of TRPV1 as a Therapeutic Target

SJ. Song, YE. Kim (Anyang, Republic of Korea)
Pain relief beyond motor cortex modulation: clinical–neurophysiological dissociation after M1-tDCS in Parkinson’s disease

A. Megía-García, Y. González Zamorano, F. Sanchez Cuesta, J. Gómez Soriano, J. Romero Muñoz (Toledo, Spain)
Painful legs moving toes spectrum disorders – a systematic review

J. Kungshamn, E. Jaakkola, J. Joutsa (Turku, Finland)
Paired cerebrospinal fluid and serum analysis of irisin and associated LC3B levels in Parkinson’s disease and atypical Parkinsonism

S. Witte, C. van Riesen, M. Bähr, F. Maass (Göttingen, Germany)
Pallidal Local Field Potentials modulation by Deep Brain Stimulation in Acquired Dystonia due to Kernicterus

F. Cammarota, E. Moro, V. Fraix, S. Chabardes, S. Meoni (Pavia, Italy)
Parkinson disease psychosis: A systematic review and meta-analysis

J. Hinkle, J. Blackband, B. Garner, K. Perepezko, C. Morrow, A. Chowdhury, K. Mills, A. Mahajan, A. Martinez-Nunez, G. Pontone (Baltimore, USA)
Parkinson’s Disease Genetics: From Monogenic Causes to Polygenic Risk and Clinical Translation

X. Liu, X. Zheng, Y. Wang, Y. Yu, H. Shang, C. Li (chengdu, China)
Parkinson’s Disease and Osteoporosis Comorbidity: A Bibliometric Analysis and Exploration of Mechanistic Pathways and Key Genes

L. Xiao, J. Fan, Y. Wu, K. Liao, L. Zhuang (Guangzhou, China)
Parkinson’s Disease and Parkinsonism Family Center Psychoeducational Program for Patients and Caregivers

M. Serini, C. Aiello, G. Garavaglia, I. Riela, D. Devoto, M. Barichella, M. Macchione, E. Sacilotto, I. Sconfietti, I. Isaias, R. Giove, A. Ranghetti, D. Calandrella, G. Pezzoli (Milano, Italy)
Parkinson’s Disease Duration at Total Knee Arthroplasty and 5-Year Vascular and Periprosthetic Outcomes: A Nationwide Matched Cohort Study

D. Kwon, H. Park (Seoul, Republic of Korea)
Parkinson’s Disease Early Diagnostic and Prognostic Biomarkers Identified by Large-scale Plasma and Cerebrospinal Fluid Proteomic Profiling

XY. Li, YL. Tang, J. Wang (Shanghai, China)
Parkinson’s disease patients with sleep disturbances: Motor and non-motor profiling

R. Guizani, A. Rekik, K. Jemai, A. Mili, H. Slimene, E. Jarrar, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)
Parkinsonism in B-Cell Maturation Antigen-Targeting CAR-T Cell Cancer Therapies

A. Zolin, V. Gao, D. Riegel, C. Snajdr-Trinch, B. Santomasso, R. Magge, S. Wesley, H. Danish, H. Sarva, H. Ooi, A. Yoo (New York, USA)
Parkinsonism Induced By An Interpeduncular Cistern Epidermoid Cyst A Case Report And Literature Review

M. Salas-Crisostomo, A. Calderon-Garciduenas, D. Lopez-Mena, H. Martinez-Hernandez (Mexico City, Mexico)
Parkinsonism Revealing a Late Form of Niemann-Pick Disease About a Case

C. Boukadir (Benaknoun; Algiers, Algeria)
Paroxismal Torticollis Revealing Cervical disc Calcifications in a Child About a Case

C. Boukadir (Benaknoun; Algiers, Algeria)
Partial Duplication of NBEA in a Patient Presenting Chorea with Incomplete Penetrance

HY. Wang, XS. Zheng, W. Luo (Hangzhou, Zhejiang Province, China)
Partnering with Community Through Co-designed Education for People Living with Parkinson’s

R. Mouer, V. Mcconvey (Camberwell, Australia)
Passive Lumbar Accelerometry Reveals Motor and Behavioral Signatures Associated with High Risk for Parkinson’s Disease

A. Ziv, R. Vaknin Greenblatt, L. Yahimovich, Y. Lachberg, A. Thaler, JM. Hausdorff, A. Mirelman (Tel Aviv, Israel)
Passive smartphone-based tremor quantification in essential tremor

J. Gerstl, S. Grigoriou (Lund, Sweden)
Patient and Caregiver Perspectives on Patient Burden of Huntington Disease Chorea and the Real‑World Impact of Deutetrabenazine Treatment

D. Claassen, W A. Dalrymple, P. Gandhi, D. Klakotskaia, M. Konings, H. Moore, K. Anderson (Nashville, USA)
Patient perspectives on meaningful symptoms and disease progression in Parkinson’s Disease (PD): Interim findings from the Patient Endpoint Preference Project (PEPP)

V. Di Foggia, A. Noyce, E. Shelton, J. Mammen, F. de Renzis, A. Hursey, N. Wickramasekera, D. Rowen, M. Wilson, D. Magalhaes, J. Holenz, G. Harrison-Jones (Coronado, Portugal)
Patient Perspectives on Telemedicine and Remote Deep Brain Stimulation Programming in Parkinson’s Disease: A Questionnaire Survey

K. Okuba, H. Kawasaki, K. Seo, M. Kobayashi, G. Oyama (Saitama, Japan)
Patient self-rated Improvements with Opicapone: From randomized trials to Phase IV studies in fluctuating Parkinson’s Disease

H. C Brigas, C. Carroll, E. Freire, M. Pötter-Nerger, A. S. Morgadinho, B. Belvisi, D. Ramos, B. Fidalgo Dias, J. Holenz, J. J Ferreira (São Mamede do Coronado, Portugal)
Patient-centered Parkinson’s services and integrated primary care in southern Ghana: patient and caregiver perceptions from a cross-sectional survey

M. Agoriwo, M. Unger, C. Joseph, E. Franzén (Cape Town, South Africa)
Patient-Defined Disease Progression in Parkinson Disease: Towards Patient-Relevant Outcome Measures

C. Gonzalez-Robles, A. Schrag, R. Weil, M. Burnell, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)
Patient-Derived α-Synuclein Kinetic Subtypes Drive Distinct Pathological Propagation Patterns and Brain Network Alterations in Parkinson’s Disease Mouse Models

W. Dai (Urumqi, China)
Pattern and progression of sudomotor dysfunction in alpha synucleinopathies

Z. Jiang, G. Chiaro, V. Iodice (London, United Kingdom)
PD Similarity Index: A Wearable Gait Biomarker Capturing the Continuum from iRBD to Parkinson Disease

S. Kim, J. Jung, P. Lee, S. Kang, M. Son, J. Jeon (Busan, Republic of Korea)
PDGFB Mutations may Induce Primary Brain Calcification via the Gain-of-Function Mechanism

RL. Sun, LB. Wang, XN. Jin, ZD. Cen, W. Luo (Hangzhou, China)
Peak Mean Skeletal Diffusivity as a Marker of Cognitive Impairment in Parkinson’s disease

W. Aye, D. Myall, T. Pitcher, S. Holdsworth, J. Dalrymple-Alford, T. Anderson, C. Le Heron, T. Melzer (Christchurch, New Zealand)
Pelizaeus Merzbacher like disease (PMLD): Neuroradiological Phenotyping

K. Shah, M. Shah (Mumbai, India)
Pelvic periosteal stimulation for Axial Rigidity in Parkinson’s Disease: A Retrospective Case Series

A. Ahn, C. Peterson, K. Ahn (Pocheon-si, Republic of Korea)
Perceived Consequences and Catastrophising Help Explain Health-Related Quality of Life in Parkinson’s Disease

V. Azoidou, E. Bhadra, E. Camboe, K. Dey, A. Zirra, K. Rowsell, C. Quah, C. Budu, T. Boyle, D. Gallagher, J. Bestwick, L. Smith, A. Noyce, C. Simonet (London, United Kingdom)
Perception of Early-Intervention Therapies and Clinically Meaningful Delays in Huntington’s Disease Onset and Progression: The Pre-HDBOI Study

A. Toumadj, I. Rodriguez-Santana, C. Mighiu, A. Arnesen, B. Balas (Lexington, USA)
Perceptions and knowledge about Parkinson’s disease fluctuations among patients and caregivers: insights from a qualitative focus group

J. Romero Muñoz, J. Herreros, C. Soria Poveda, I. Santamaría Rodríguez (Pozuelo de Alarcón, Madrid, Spain)
Performance of the functional staging of Parkinson’s disease using the Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) in the Critical Path for Parkinson’s (CPP) Integrated Parkinson’s Database

DA. Olszewska, D. Ghosh, S. Luo, C. Marras (Cork, Ireland)
Perioperative and Longitudinal Outcomes Following Deep Brain Stimulation in Patients with Movement Disorders: A Retrospective Review From a Movement Disorder Program

Z. Mohseni (Fairfax, USA)
Perioperative outcomes for patients with Parkinson’s disease – a scoping review

A. Paveley, L. Bruzze, S. Haworth, A. Lindsay-Perez, M. Smith, E. Henderson (Bristol, United Kingdom)
Peripheral Inflammatory Biomarkers as Predictive Indicator for Parkinson’s Disease: a Systematic Review and Meta-Analysis

H. Hussien, A. Hegazi, A. Elsaid (Dakahlia, Egypt)
Peripheral Inflammatory Markers and Clinical Correlations in Parkinson’s Disease Patients Carrying LRRK2 G2385R and R1628P Variants

HX. Ding, TS. Toh, NJ. Zulkefli, NS. Zulhaimi, AN. Khairul Anuar, JW. Hor, YW. Tay, IX. Kong, YC. Pang, R. Rajasuriar, SY. Lim, AH. Tan, LC. Lit (Kuala Lumpur, Malaysia)
Peripheral neuropathy (NP) in advanced Parkinson’s disease (PD) patients treated with continuous subcutaneous foslevodopa/foscarbidopa (fLD/fCD)

H. Salhi, A. Gravier, V. Garbage, B. Cormier, A. Dormeuil, A. Petit, A. Zayed, V. Perrain, T. Gendre, P. Remy (Creteil, France)
Perplexing Presentation of Myasthenia Gravis in an Elderly Patient with Essential Tremor and Parkinson’s Disease Complex Case Report

I. Eltazi, B. Canibano, O. Suliman (Doha, Qatar)
Perrault Syndrome in a Young Adult with Co-existing HSD17B4 Variant and CNBP Mutation

I. Molina, D. Mohanty (Albuquerque, USA)
Personal Views of Aging in Parkinson’s Disease: How Do They Relate to Clinical, Cognitive and Behavioral Functioning?

ML. Nasi, E. Carbone, M. Vincenzi, D. Lupi, A. Antonini, E. Borella, R. Biundo (Padova, Italy)
Personalised Selection Of Device-Aided Infusion Therapies In Advanced Parkinson’s Disease: A European Expert Delphi Consensus

V. Correa-Gallego, J. Castrillo, K. Chaudhuri, T. Henriksen, W. Jost, N. Kovács, O. Rascol, B. Popescu (Reading, United Kingdom)
Personality Dynamics and Cognitive Impairment and Related Neuropsychiatric Symptoms in Patience with Different Movement Disorders

M. Kulsum, M. Naaz, A. Das, A. Das, T. Dolai, S. Majumdar (Kolkata, India)
Personalized Factors Influencing Technological Solutions for Mobility – Insights from A Wearable Device in Parkinsons Disease

A. Desai, R. Rajput (Mumbai, India)
Personalized Rhythmic Cueing Differentially Improves Straight Walking and Turning in Parkinson’s Disease

CY. Chien, YH. Liu, YL. Chen, CL. Lin, JSK. Chang, CCK. Lin (Tainan, Taiwan)
PEST-PD: Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides.

E. Cubo, L. Gomez-Cuadrado, D. Garcia-Garcia, A. Canepa, B. Alonzo-Nuñez, D. de Lara (Burgos, Spain)
Pesticide Exposure and Motor Severity in Parkinson’s Disease in a Mexican Population: A Retrospective Longitudinal Cohort Study

J. Espinoza-Solares, A. Tapia, L. Cortés, J. López-Moreno, A. Cervantes-Arriaga, M. Rodriguez-Violante (Ciudad de México, Mexico)
Pesticide Exposure and Smoking in Parkinson’s Disease in Kyrgyzstan: A Case–Control Study

A. Kubanychbekova, A. Ismailova, E. Zhunusova, S. Kyialbekova, A. Abdumalikova, C. Shambetova (Bishkek, Kyrgyzstan)
PET Imaging of Presynaptic Terminals with [18F]SynVesT-1 in Premanifest Huntington’s Disease

J. van Opstal, G. Vanderlinden, A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)
Pharmacogenomic Analysis of KM-819-Related Hepatotoxicity in Patients with Multiple System Atrophy

J. Han, R. Andrade, ES. Björnsson, JH. Lewis, MI. Lucena, S. Go, S. Stankeviciute, G. Aithal, G. Kim, C. Lee, C. Barlow, E. Kim (Bundang-gu, Republic of Korea)
Pharmacoscintigraphic Evaluation and Safety of a Novel, Dual-pulse, Delayed-release carbidopa/levodopa Tablet for Bedtime Dosing

A. østerskov, A. Elvang, T. Sager, K. Christensen, F. Macdougall, L. Corry (Horsholm, Denmark)
Phase 1 Study of BT-267, a potent, selective, brain-penetrant, and oral small molecule inhibitor of LRRK2

T. Dam, D. Hilt, E. Remeeva, A. Mathias, M. Mcgill, K. Dokukina, A. Pushechnikov, R. Karapetyan, V. Kazey, I. Dukes, N. Savchuk (Dover, USA)
Phase 1 Study of BT-409, a potent, selective, brain-penetrant, and oral small molecule inhibitor of NLRP3 in Healthy Volunteers and Adults with Parkinson’s disease

T. Dam, A. Mathias, E. Remeeva, D. Hilt, M. Mcgill, A. Pushechnikov, R. Karapetyan, N. Savchuk, I. Dukes, V. Kazey, K. Dokukina (Dover, USA)
Phase 2 Trial for the Treatment of Early-stage Parkinson’s Disease with TJ0113, a Small Molecule Mitophagy Activator

W. Luo, ZD. Cen, XF. Cen, XH. Chen, S. Wu, Y. Tan, LQ. Mao, XL. Mao, B. Zhang, W. Lv, SZ. Liu, YP. Wang, D. Liu, HG. Xia (Zhejiang, China)
Phasic Hemidystonia Secondary to Cavernoma: A Case of Sustained Response to Botulinum Toxin

N. Tahsin, D. Dash, A. Elavarasi (Limerick, Ireland)
Phenoconversion from Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: A multimodal Imaging Study

J. Ebina, K. Kamiya, M. Hori, M. Shibukawa, J. Nagasawa, T. Hirayama, S. Mizumura, O. Kano (Tokyo, Japan)
Phenomenological Gaps in Rating Scales for Blepharospasm Motor Severity

J. Lee, C. Rusandhy, V. Nguyen, D. Peterson (La Jolla, USA)
Phenotype – lesion correlation in post-stroke movement disorders: Lessons learnt from two cases

A. Mukherjee, S. Pandey (Kolkata, India)
Phenotypic and Genotypic Spectrum of MAPT-associated Parkinsonism in a Multi-ethnic Malaysian Cohort

JP. Schee, YW. Tay, TS. Toh, AN. Khairul Anuar, HX. Ding, JWY. Tee, AL. Lee, A. Ahmad-Annuar, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)
Phenotypic Evolution from Nonfluent PPA to PSP

S. Park (Sejong-si, Republic of Korea)
Phenotypic Overlap Between Essential Tremor and Dystonic Tremor: Diagnostic Features, Misclassification, and Clinical Implications :A Systematic Review

S. Kakde, M. Kakde, S. Kakade (Aurangabad, India)
Phenotypic Spectrum, Neuroimaging Findings, Genotypic Correlates, and Treatment Outcomes in KMT2B-Related Disorder: A Multicenter Retrospective Cohort Study

S. Roychowdhury, H. Alfaris, A. Menetrey, D. Munoz, P. Bisarad, M. Huynh, J. Ganguly, M. Kruer, A. Leblanc-Millar, G. Ibrahim, C. Gorodetsky (Toronto, Canada)
Phenytoin Intoxication Masquerading as Generalized Chorea: A Case of Iatrogenic Double-Prescribing

K. Tayade (Mumbai, India)
Physical Activity is Associated with Attenuated Motor and Cognitive Progression in Parkinson’s Disease

DW. Ryu, KR. Duque, J. Abanto, L. Marsili, NC. Paredes, AH. Gorriti, H. Deraz, E. Hill, A. Duker, AJ. Espay (Seoul, Republic of Korea)
Physical Proximity Influences Mobility in Advanced Parkinson’s Disease Patient–Caregiver Dyads.

N. Harroum, R. Ruben Jordan, C. Duval (Montréal, Canada)
Physiotherapists’ Clinical Reasoning When Selecting Compensatory Strategies for Gait Impairments in Parkinson’s Disease

ZY. Wan, S. Davenport (Singapore, Singapore)
Pilot feasibility study of home-based assessment of aspiration risk among people with Parkinson’s disease in rural northern Tanzania

R. Haggie, T. Neal, I. Terry, W. Eliamini, S. Linus, S. Ally, C. Nye, M. Dekker, S. Urasa, D. Mushi, R. Walker, C. Dotchin (Bristol, United Kingdom)
Pilot Study of Vibrotactile Gait Cueing with the NUSHU X Sneaker in Parkinson’s Disease

D. Kashyap, K. Nicholson, B. Katz, C. Snajdr-Trinch, M. Mcmichael, N. Hellmers, HY. Ooi, H. Sarva, A. Yoo (New York, USA)
Plasma and CSF Autoimmune Markers in Orthostatic Tremor Insights from a Prospective Tertiary Centre Cohort

P. Becker, M. Silsby, A. Martin, L. Williams, S. Nagaratnam, J. Qiu, D. Wilson, S. Xi, M. Georgiades, N. Jeyakumar, M. Lin, D. Brown, V. Fung (Sydney, Australia)
Plasma Exchange and Reduced Parkinson’s Disease Diagnosis: A Nationwide Sequence Symmetry Analysis

S. Ueno, T. Saito, S. Nojiri, M. Nagao, Y. Nishizaki, M. Ishijima, T. Hatano (Bunkyo-ku, Japan)
Plasma Exosomal Cytokines as Longitudinal Biomarkers and Predictors of Parkinson’s Disease Progression

CT. Hong, CC. Chung (New Taipei, Taiwan)
Plasma Extracellular Vesicle Protein Biomarker Discovery for Monogenic and Sporadic Dystonia

Z. Caffall, J. Jordan, A. Norain, L. Longyear, G. Aldykiewicz, T. Tran, A. Wagle-Shukla, N. Sharma, A. Nixon, E. Soderblom, N. Calakos (Durham, USA)
Plasma Fibrinogen Associates with Dopaminergic Neurodegeneration Independent of Peripheral Inflammation in drug-naïve Parkinson’s Disease

T. Umehara, Y. Muraoka, Y. Nakayama, M. Mimori, M. Ozawa, T. Kitagawa, H. Matsuno, S. Omoto, R. Sengoku, Y. Iguchi (Tokyo, Japan)
Plasma p-tau217 outperforms p-tau181 as a biomarker of Alzheimer’s disease co-pathology in the Lewy Body Disorders spectrum

E. Fiorenzato, S. Cauzzo, G. Musso, R. Biundo, C. Ceolin, C. Fogliano, C. Cosma, W. Meissner, V. Misenti, S. Moz, ML. Nasi, F. Vianello, R. Manara, M. Montagnana, G. Sergi, A. Antonini (Padova, Italy)
Plasma Phospho-Tau217 and Neuromelanin-Sensitive MRI as Candidate Biomarkers in Beta-Propeller Protein-Associated Neurodegeneration

JH. Lee, YS. Kim (Yangsan, Republic of Korea)
Plasma Proteomics in PSP

S. Neo, S. Chia, J. Tan, T. Leong, Z. Xu, KY. Tay, WL. Au, LCS. Tan, A. Ng (Singapore, Singapore)
Plasma Proteomics Reveals Altered Redox Balance And Protein Homeostasis In Spinocerebellar Ataxia Type 12

S. Ansari, I. Sadaf, A. Bhardwaj, S. Haldar, J. Rungta, S. Sengupta, R. Banerjee, J. Ganguly, D. Dutta, S. Mukherjee, P. Basu, R. Pal, S. Chattarji, T. Maiti, S. Choudhury, H. Kumar (Kolkata, India)
Platelet Lipididomic and Alpha-Synuclein as Peripheral Biomarkers of Disease Progression and Risk in GBA1-Associated Parkinson’s Disease

G. Uras, S. Lucas Del-Pozo, V. Lentini, A. Pantaleo, D. Hughes, P. Caboni, C. Manis, A. Schapira (London, United Kingdom)
PLIC Fractional Anisotropy and Motor Outcome After Functional Neurosurgical Treatment in Parkinson’s Disease

J. Brainer Lima, P. Brainer Lima, A. Brainer Lima, M. Cavalcanti, M. Sales, S. Laurentino, R. Bandim, G. Britto Brainer, P. Brainer Lima (Recife, Brazil)
Podcast Based Learning in Movement Disorders: Educational Impact of the Podcast Movement Disorders Around the World

N. Bujala (New York, USA)
Point-of-Care Neuromuscular Ultrasound With Fractal Biomarkers for Stratification of Neuropathic and Myogenic Drivers of Motor Decline

R. Bubnov, L. Kalika, Z. Pilecki (Kyiv, Ukraine)
POLG-Related Disease Mimicking Progressive Supranuclear Palsy with Selective Vertical Gaze Restriction

E. Orozco, W. Wagrees, C. Hainline, G. Suarez-Cedeno (Albuquerque, USA)
Polygenic Risk Score-Based Phenome-Wide Association Study and Mendelian Randomization of Multiple System Atrophy in the UK

XH. Chen, JW. Chen, W. Luo (Hangzhou, China)
Polymyographic Features Suggestive of Functional Etiology in Patients with Cervical Dystonia

M. Minar, Z. Kosutzka (Bratislava, Slovakia)
Polypharmacy and its Impact in Individuals with Parkinson’s Disease: Theory- and Data-Driven Approaches

E. Nguyen, S. Maji, B. Klinedinst, N. Meier (Irvine, USA)
Portosystemic Shunt Related Parkinsonism in Acquired Hepatocerebral Degeneration With Persistent Pallidal T1 Hyperintensity

A. Pronina, N. Fedotova, M. Usupova, E. Brill (Moscow, Russian Federation)
Positive Results from a Global Phase 3 Trial (IB1001-303) Evaluating Levacetylleucine in Ataxia-Telangiectasia

B. Zanrucha, M. Patterson, T. Bremova-Ertl, M. Strupp, J. Raymond, J. Kerthi, T. Fields, I. Billington, K. Martakis (Austin, USA)
Post-COVID Movement Disorders: Clinical Spectrum and Mechanisms A Systematic Review

S. Kakde, M. Kakde, S. Kakade (Aurangabad, India)
Posterior Cortical Hypometabolism in GBA1 Variant Carriers with and without Parkinson’s Disease

M. Avenali, R. Malito, P. Mitrotti, R. Calabrese, L. Gallo, T. Filidei, A. Panzacchi, A. Samanes Gajate, G. Pepe, R. Stiuso, M. Picascia, M. Todisco, L. Bandirali, P. Di Martino, D. Perani, A. Chiti, C. Tassorelli, E. Valente, S. Caminiti (Pavia, Italy)
Posterior tibial nerve Stimulation in the management of Urinary Disorders in Parkinson’s Disease Experience of the National Hospital Center of Pikine

F. Niakam M., N. Mundih, M O. Ngoule, A. Ngassaki, SA. Sow, AM. Diop, J. Kahwagi, MD. Dia, C. Kwama, SA. Jouonang, CB. Bangweni, M. Boukoulou, AG. Faye, C. M. Samba, S. Kamali, M. Ndiaye, M. Fall (Dakar, Senegal)
Poststroke Movement Disorders: Clinical, Neuroimaging and Electrophysiological correlates

S. Yellaturi, S. Pandey (Faridabad, India)
Postural Disorders in Parkinson’s Disease: The Role of Botulinum Toxin – A French prospective cohort

M. Pougeon, C. Tourlet, S. Grimaldi, A. Eusebio, JP. Azulay, F. Fluchere (Marseille, France)
Postural Stability After CSF Drainage in Idiopathic Normal Pressure Hydrocephalus: Association with Gait Response

HJ. Chang, JH. Kim, EJ. Kwon, S. Jeong, E. Oh (Daejeon, Republic of Korea)
Postural Sway Frequencies in Isolated REM Sleep Behavior Disorder Might Indicate Subtle Motor Impairments as Prodromal Marker of Parkinson’s Disease

D. Engel, P. Carlson-Kuhta, M. Lim, H. Hameed, K. Ehgoetz Martens, F. Horak, M. Mancini, M. Sommerauer (Bonn, Germany)
Power Spectral Density Increases Covary with Clinical Overstimulation During Dystonia Deep Brain Stimulation Programming

P. Bisarad, M. Pascual, J. Kelbert, S. Chinander, R. Gelineau-Morel, C. Gorodetsky, A. Hewitt, T. Larsh, N. Lucente, J. O'Malley, L. van Derwerf, J. Hauptman, T. Sanger, F. Ponce, M. Kruer, J. Thompson (Phoenix, USA)
PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

N. Singh, V. Singh (bathinda, India)
PPP2R2B Splice Variant Dysregulation Promotes Mitochondrial Association and Neuronal Apoptosis in iPSC-Derived Neurons from Spinocerebellar Ataxia Type 12 Patient

S. Sengupta, R. Banerjee, J. Rungta, B. Reddy, S. Ansari, R. Khatun, R. Mukhopadhyay, S. Pal, J. Ganguly, D. Dutta, S. Mukherjee, P. Basu, S. Choudhury, R. Pal, S. Chattarji, H. Kumar (Kolkata, India)
PPP2R5D Variants in Patients Diagnosed With Parkinson’s Disease. A Large‑Scale Multi‑Cohort Analysis

I. Keller Sarmiento, R. Bovenzi, V. Quintana, G. Cogan, A. Brice, A. Gajos, M. Bozi, L. Lange, G. Benbir Senel, B. Tserensodnom, H. Kim, M. Marti, A. Dilliott, H. Morris, S. Lim, A. Tan, R. Alcalay, J. Trinh, C. Klein, N. Mencacci (Chicago, USA)
Prasinezumab in Early-Stage Parkinson’s Disease: Additional Data from the PADOVA Study

T. Nikolcheva, G. Pagano, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, N. Pross, A. Monnet, G. Kerchner, P. Brundin, A. Bonni (Basel, Switzerland)
Prasinezumab’s Impact on Neuromelanin- and Iron-Sensitive MRI Biomarkers in Parkinson’s disease: Findings From the PADOVA Phase IIb Study

T. Kustermann, š. Holiga, R. Akande, J. Anzures-Cabrera, N. Pross, A. Monnet, T. Nikolcheva, G. Pagano (Basel, Switzerland)
Precision Gene Therapy Results in Clinical Benefit and Developmental Gains in Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): The UK Experience

A. Spagarino, A. Salazar-Villacorta, R. Spaull, A. Soo, J. Hassell, S. Pope, S. Heales, R. Shihurkar, L. Carr, K. Aquilina, M. Kurian (London, United Kingdom)
Predicting Dementia in Parkinson’s Disease Using Blood-Based Proteomics

R. Real, Y. Kordovska, O. Swann, A. Nodehi, Y. Ben-Shlomo, N. Williams, D. Grosset, J. Hardy, A. Heslegrave, H. Zetterberg, H. Morris (London, United Kingdom)
Predicting Levodopa Responsiveness in Early Parkinson’s Disease Using Neural Perturbation Inference-Based Effective Connectivity

G. Xing, R. Siming (Guang Zhou, China)
Predicting Parkinson’s: Navigating Risk, Rights, and Regulation

J. Braun, B. Schmitz-Luhn (Bonn, Germany)
Prediction of Cognitive Decline After STN-DBS in Parkinson’s Disease Using Preoperative Electroencephalography and a Deep Learning Model

K. Iwami, K. Eguchi, S. Shirai, H. Yaguchi, I. Yabe (Sapporo, Japan)
Predictors of Clinical Progression Over a Decade in GBA1 versus LRRK2 Non-Manifesting Carriers

M. Stark, I. Schoen, E. Mamikonyan, D. Weintraub (Philadelphia, USA)
Predictors of cognitive trajectories in Parkinson’s disease with mild cognitive impairment after STN-DBS: a diffusion MRI study

E. Igami, H. Takeshige-Amano, K. Takabayashi, S. Ueno, R. Kamo, D. Samayoa, W. Sako, T. Ogawa, H. Iwamuro, A. Umemura, G. Oyama, S. Aoki, K. Kamagata, N. Hattori, T. Hatano (Tokyo, Japan)
Predictors of disease progression in progressive supranuclear palsy and corticobasal syndrome

D. Vaughan, R. Fumi, A. Mathur, R. Real, E. Lam, M. Theilmann Jensen, Y. Kordovska, O. Serrano Assensio, M. Hodgson, A. Heslegrave, H. Zetterberg, U. Nath, M. Hu, A. Church, J. Coebergh, N. Pavese, B. Ghosh, J. Rowe, E. Jabbari, H. Morris (London, United Kingdom)
Predictors of Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Elsaid, H. Hussien, A. Hegazi (Dakahlia, Egypt)
Predictors of Parkinson’s Disease Phenoconversion in Non-manifesting LRRK2 Carriers

JH. Ng, X. Deng, EK. Tan (Singapore, Singapore)
Predictors of Secondary Non-Response to Botulinum Neurotoxin Type-A in Cervical Dystonia: A Multi-Center Egyptian Study

E. Abed (Cairo, Egypt)
Predictors of Severity of Psychosis in Parkinson’s Disease: A 3-year longitudinal cohort study

R. Sharma, J. Flanigan, B. Shah, J. Patrie (Charlottesville, USA)
Predictors of Shunt Placement for Patients with Normal Pressure Hydrocephalus following a Multidisciplinary Evaluation

G. Yu, D. Terry, L. Acosta (Philadelphia, USA)
Pregnancy and Breastfeeding in Early-Onset Parkinson’s Disease:Therapeutic Challenges of Levodopa Monotherapy.A case Report.

K. Salinas-Barboza, J. Altamirano, L. Salinas-Yañez, D. Avecilla-Bonilla (CDMX, Mexico)
Preliminary Genetic Spectrum of Parkinson’s Disease in the Israeli PD GENEration Cohort

N. Omer, R. Cohen, T. Gurevich, M. Kalish, A. Thaler, V. Linveh, P. Ponger, M. Cohen, G. Yahalom, I. Harari, T. Fay-Karmon, T. Davidi, A. Saar, L. Greenbaum, S. Hassin-Baer, L. Caboy, A. Dilliot, M. Thom, M. Dini, R. Alcalay (Tel Aviv, Israel)
Presence of Common Psychiatric Diagnoses Did Not Impact the Efficacy or Safety of Ecopipam in Individuals With Tourette Syndrome

J. Mcguire, J. Flatt, G. Karkanias, F. Munschauer, T. Cunniff, S. Wanaski, E. Greenberg (Baltimore, USA)
Preservation of Cognition Following Intravenous Mesenchymal Stem Cell Therapy in Parkinson’s Disease: Secondary Analysis of a Randomized Trial

J. Martinez-Lemus, T. Thomas, C. Green, T. Ellmore, F. Triolo, S. Olson, J. Suescun, E. Tharp, C. Onuigbo, R. Ritter Iii, M. Schiess (Houston, USA)
Preserved Neuroplasticity in Patients Affected by Parkinson’s Disease Responders to External Auditory Cueing Strategies

A. Botta, V. Romano, J. Nonnekes, M. Gilat, A. Mirelman, E. Pelosin, L. Avanzino (Genoa, Italy)
Prevalence and associated factors of sarcopenia among Thai patients with ambulatory Parkinson’s disease

J. Intum, P. Lolekha, K. Chupisanyarote (Khlong Luang, Thailand)
Prevalence and characteristics of sleep disorders in Parkinson’s disease: an Argentine cohort.

F. San Juan, F. Echeverria, S. Rodriguez, T. Arakaki, N. Garreto (CABA, Argentina)
Prevalence and Clinical Determinants of Cognitive Impairment in a Diverse Parkinson’s Disease Cohort

A. Zirra, K. Dey, E. Camboe, E. Bhadra, R. Laban, B. Huxford, S. Hussain-Ali, C. Simonet, C. Budu, D. Gallagher, S. Waters, V. Azoidou, T. Boyle, A. Lees, M. Perinan, C. Marshall, A. Noyce (London, United Kingdom)
Prevalence and clinical predictors of depressive symptoms in Parkinson’s Disease: an analysis from the Global Parkinson’s Genetics Program

P. Reyes-Pérez, T. Perinan, D. Delgado, A. Lazaro-Figueroa, A. Medina-Rivera, A. Ruiz-Contreras, S. Alcauter-Solorzano (Mexico City, Mexico)
Prevalence and neuroimaging presentations of Parkinsonism patients with p.R544C NOTCH3 mutation in Taiwan

JJ. Lin (Chu-Shang Jenn, Nantou, Taiwan)
Prevalence and Profile of Non-Motor Symptoms in Parkinson’s Disease in the Uzbek Population Assessed with the MDS-NMS Scale

D. Daminov (Tashkent, Uzbekistan)
Prevalence and Socio-Demographic Profile of Parkinson’s Disease in Rural Tanzania

S. Urasa, M. Dekker, J. Nyonyi, W. Howlett, D. Mushi, G. Lyimo, G. Kapanda, J. Rogathi, A. Makundi, N. Fothergill-Misbah, J. Nsengimana, Y. Okkaoglu, C. Dotchin, R. Morton, R. Walker (Moshi, United Republic of Tanzania)
Prevalence and Treatment Patterns of Anxiety Symptoms in Parkinson’s Disease

J. Lam, K. Tosefsky, S. Appel-Cresswell (Vancouver, Canada)
Prevalence of drooling in Parkinson’s disease: a multi-center observational study

M. Iijima, R. Morimoto, K. Suzuki, T. Osada, S. Nogawa, Y. Okuma (Tokyo, Japan)
Prevalence of Functional Neurological Signs in Parkinson’s Disease: A Multicenter Cross-Sectional Study

A. Baghaei, A. Espay, M. Tagliati, M. Rabin, K. Dashtipour (Loma Linda, USA)
Prevalence of Pain and Effect of Scalp Block on Pain Scores During MRI Guided Focused Ultrasound Lesioning Procedure

E. Davies, R. Srinivasaiah, J. Panicker, D. Damodaran, M. Radon, A. Macerollo, J. Farah (Liverpool, United Kingdom)
Prevalence of Parkinson’s Disease in the South Tongu District of Ghana and Projections of Current and Future Disease Burden (2026 – 2040)

M. Cham, E. Deh, D. Adanfo, V. Obese, R. Morton, R. Cilia, R. Odikro, E. Agbenyegah, E. Ame-Bruce, N. Fothergill-Misbah, O. Ojo, A. Akpalu, C. Dotchin, F. Baiden, N. Okubadejo, R. Walker (Sogakope, Ghana)
Prevalence of sarcopenic obesity and its association with non-motor symptoms in early Parkinson’s disease

S. Choi, R. Kim, J-Y. Lee (Incheon, Republic of Korea)
Probabilistic Mapping of Subthalamic Beta and Theta Subcircuits Reveals Segregated Connectivity and Deep Brain Stimulation Outcomes in Parkinson’s Disease

E. Schmehr, C. Schedlich-Teufer, J. Strelow, T. Schüller, T. Dembek, A. Horn, V. Visser-Vandewalle, G. Fink, J. Baldermann, M. Barbe (Cologne, Germany)
Probable Corticobasal Syndrome Presenting as Writer’s Cramp: A Case Report

B. Dias, K. Alves, T. Goncalves, D. Faria, R. Pinto, S. Silva (Sao Paulo, Brazil)
Probable RBD and Anxiety in Early Parkinson’s Disease Predict Subsequent Functionally Disabling Medication-Refractory Tremor

D. Ledingham, S. Sathyanarayana, R. Iredale, C. Stewart, V. Foster, D. Galley, M. Baker, N. Pavese (Newcastle Upon Tyne, United Kingdom)
Probiotic Y7 Intervention Is Associated with Improved Motor, Gut-Related, and L-DOPA-Related Outcomes in a Rat Model of Parkinson’s Disease

HY. Huang, TH. Yeh, SP. Tsao, DY. Wang, TJ. Chen (Taipei City, Taiwan)
Processing Speed across Huntington’s Disease Stages and its association with Striatal PDE10A Density

C. Madrigal Esquivel, A. Rangel Cristales, A. Wood, F. Turkheimer, J. Badenoch, J. Valera Bermejo, J. Staunton, M. Moretto, M. Veronese, M. Hartmann, N. Martin, N. Palasits, O. Makos, P. Eze, P. Tall, S. Williams, D. van Wamelen (London, United Kingdom)
Prodromal Parkinson’s Disease in Singapore: Motor and Non-Motor Symptom Patterns

R. Chen, Y. Nah, S. Ng, R. Hoe, E. Tan, Z. Xu, L. Tan (Singapore, Singapore)
Prognostic Factors for Survival in Multiple System Atrophy: A Retrospective Cohort Study with Focus on Surgical Interventions

H. Shimizu, T. Yamamoto, Y. Takahashi (Kodaira, Tokyo, Japan)
Prognostic Impact of GBA Variants on Mortality in Parkinson’s Disease: A Systematic Review and Meta-Analysis

N. Chan, A. Raphael, J. Kim, A. Haryanto, T. Khoo (Southport, Australia)
Progression and disability in Parkinson’s disease: what else can be done?

S. Shtaimets, а. Agasheva, I. Zhukova, D. Novotnyy, N. Zhukova (Tomsk, Russian Federation)
Progressive Dynamic Functional Network Disorganisation and its Association with Phenoconversion in Isolated REM Sleep Behaviour Disorder: A Multicentre Study

L. Churchill, J. Anderson, A. Ignatavicius, A. Konuri, M. Johansson, R. Gaurav, S. Lehéricy, S. Lewis, E. Matar (Sydney, Australia)
Progressive Lifelong Chorea with Spastic Paraparese and Cerebellar Ataxia Associated with Two Heterozygous Variants in the SYNE1 Gene: A Case Report

I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg (Zagreb, Croatia)
Progressive Spastic Ataxia Associated with a GRM1 Variant in a Young Female

WL. Lin, TY. Lin, TL. Lee (Tainan, Taiwan)
Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

G. Salazar, I. Caballero (Terrassa, Spain)
Proposed cognitive indices for the Parkinson’s Progression Markers Initiative

D. González, W. Kent, G. Springer, A. Karstens (Chicago, USA)
Prosaposin differentially modulates lipid metabolism of striatal and non-striatal dopamine D1 receptor-expressing neurons and regulates L-DOPA-induced dyskinesia

Y. He, I. Kaya, Y. Yang, A. Nilsson, R. Shariatgorji, I. Mantas, X. Zhang, P. Andren, P. Svenningsson (Solna, Sweden)
Prosodic speech variability is associated with speech-related stigma in Parkinson’s disease

H. Jergas, T. Tienkamp, T. Thies, V. Stopic, G. Fink, D. Mücke, M. Barbe, A. Sauerbier (Cologne, Germany)
Prospective Comparison of Volumetric and Diffusion MRI Biomarkers for Multiple System Atrophy

F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, G. Kuchcinski, C. Moreau (Lille, France)
Prospective Evaluation of a Video-Based Motor Assessment Workflow: Feasibility, Usability, and Data Quality

B. Bridges, O. Hares, E. Nishat, R. Nasir, R. Singh (St. John's, Canada)
Prospective International Registry Evaluating Real-World Clinical and Quality-of-Life Outcomes of Directional Deep Brain Stimulation in Essential Tremor

G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Barbe, M. Blázquez Estrada, F. Clement, J. Lee, S. Jaumà Classen, D. Pedrosa, J. Volkmann, A. Oliveira, S. Paschen, C. Honey, M. Fleischer, A. Schnitzler, W. Chang, L. Chen, R. Shivacharan, E. Goldberg (Kiel, Schleswig-Holstein, Germany)
Proteome-Wide Association and Mendelian Randomization Analyses Identify Plasma GUSB as a Potential Biomarker for Multiple System Atrophy

X. Wang, X. Chen, W. Luo (Hangzhou, China)
Proteomics Reveals Sex- and Age-of-onset-Stratified Immune Dysregulations in Parkinson’s Disease

X. Lu, J. Zhang, X. Cheng, J. Cheng, C. Ke, C. Liu, C. Mao (Suzhou, China)
Protocol for Rapidly Adaptive Deep Brain Stimulation to improve Freezing of Gait in Patients with Parkinson’s Disease

J. Al Ali, A. Gala, B. Kern, J. Mckay, C. Buetefisch, S. Miocinovic (Atlanta, USA)
Proximity Ligation Assay Reveals Early Tractopathy in Parkinson’s Disease

Y. Fu, F. Su, G. Halliday (Sydney, Australia)
Psychiatric manifestations in premanifest Huntington’s disease as early indicators of motor onset: a systematic review

E. Pérez Rodríguez, R. Cundapí González, I. González López, K. Gálvez Deleón, S. Domínguez Castro, D. Velázquez Ruiz, M. Serrano Velázquez, O. Barrios Julian (Tapachula, Mexico)
Psychiatric Profile of Screen Failures for Deep Brain Stimulation (DBS) Candidacy Evaluation: A Retrospective Cohort Study at a large tertiary referral center

J. Purks, A. Barnes, J. Fenn, P. Graese, D. Ferrara, D. Schiehser, M. Okun, C. Hess, G. Pontone, D. Bowers, D. Davydow (Gainesville, USA)
Psychiatric Profiles in Parkinson: A Cluster Analysis of Cognitive Performance

R. Trejo-Ayala, H. Trujillo-Guerra, P. Téllez-Hernández, K. Trejo-Ayala, B. Chávez-Luévanos, I. Estrada-Bellmann, X. Ortiz-Jiménez (Monterrey, Mexico)
Psychiatric Symptoms and Quality of Life in Huntington’s Disease Evidence from a Brazilian Cohort

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)
Psychometric Assessment of a Modified Version of the Unified Multiple System Atrophy Rating Scale Part I

AK. Berger, A. Rieckmann, K. Nighah, S. Zanigni (Valby, Denmark)
Psychosis in Parkinson’s Disease Patients Treated with Continuous Subcutaneous Foslevodopa/Foscarbidopa: A Real-World Observational Study.

M. Angerri Nadal, C. Marzal Espi, R. Gomez Llopico, S. Jauma Classen, M. Calopa Garriga, H. Bejr-Kasem Marco (Barcelona, Spain)
Psychotic Symptoms and Cognitive Impairment in Huntington’s Disease

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)
Pueraria tuberosa improves the locomotion defects in Drosophila model of FRDA

R K. Yadav, D. Talukdar, V. Swarup, A. Ahuja, A. Srivastava, M. Aski, P. Yadav (New Delhi, India)
Pulsatile Striatal Dopamine Dynamics Drive Levodopa Induced Dyskinesia In Advanced Parkinson Disease

L. Su, A. Li, Z. Li, Y. Guo (Shanghai, China)
Pulse-Width Dependent Motor Performance in Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: Evidence for a Kinematic Optimum Near 50 µs in Hand Movement

P. Köberle, N. Banaschewski, Y. Cordes, G. Adacay, J. Volkmann, M. Reich, F. Lange (Würzburg, Germany)